Alpha Cognition (NASDAQ: ACOG) recently received a number of ratings updates from brokerages and research firms: 8/20/2026 – Alpha Cognition is now covered by B. Riley Financial, Inc.. They set a “buy” rating and a $21.00 price target on the stock. 8/19/2026 – Alpha Cognition is now covered by B. Riley Financial, Inc.. They set […]

FOX (NASDAQ: FOXA) recently received a number of ratings updates from brokerages and research firms: 8/25/2026 – FOX had its “buy” rating reaffirmed by Guggenheim. They now have a $85.00 price target on the stock. 8/15/2026 – FOX was upgraded by Wall Street Zen from “hold” to “buy”. 8/14/2026 – FOX had its “buy” rating […]

A number of research firms have changed their ratings and price targets for JOYY (NASDAQ: JOYY): 8/28/2026 – JOYY was upgraded by Weiss Ratings from “hold (c-)” to “buy (b)”. 8/26/2026 – JOYY had its “buy” rating reaffirmed by Jefferies Financial Group Inc.. They now have a $87.00 price target on the stock. 8/26/2026 – […]

Several analysts have recently updated their ratings and price targets for Revolution Medicines (NASDAQ: RVMD): 8/31/2026 – Revolution Medicines had its price target raised by Needham & Company LLC from $240.00 to $275.00. They now have a “buy” rating on the stock. 8/28/2026 – Revolution Medicines had its price target raised by UBS Group AG […]

Several analysts have recently updated their ratings and price targets for Alto Neuroscience (NYSE: ANRO): 8/29/2026 – Alto Neuroscience was upgraded by Wall Street Zen from “sell” to “hold”. 8/20/2026 – Alto Neuroscience was upgraded by Zacks Research from “strong sell” to “hold”. 8/17/2026 – Alto Neuroscience had its price target raised by HC Wainwright […]

Several analysts have recently updated their ratings and price targets for Fortune Brands Innovations (NYSE: FBIN): 8/24/2026 – Fortune Brands Innovations is now covered by DA Davidson. They set a “buy” rating and a $64.00 price target on the stock. 8/24/2026 – Fortune Brands Innovations is now covered by Wells Fargo & Company. They set […]

Several analysts have recently updated their ratings and price targets for MiMedx Group (NASDAQ: MDXG): 8/29/2026 – MiMedx Group was upgraded by Wall Street Zen from “sell” to “hold”. 8/27/2026 – MiMedx Group was upgraded by Weiss Ratings from “sell (d)” to “sell (d+)”. 8/27/2026 – MiMedx Group had its price target raised by Craig […]